Cerebriu, a Danish medical technology start-up focused on faster, personalized diagnostic imaging, engaged BioPort to help them identify a U.S. Radiology Department to conduct a pre-FDA pilot. We were fortunate enough to work with the leadership at SUNY Upstate to gain the interest of the Neuroradiology Department including Dr. Sylvie Destian. They have not only agreed to participate in a Retrospective Study pre-FDA but also be involved in a Prospective Clinical Trial to help achieve FDA approval.
In addition to helping identify and secure a clinical trial partner, the team at BioPort will also be in a position to help Cerebriu with with their FTO, Market Access, and Sales & Marketing strategy.
Cerebriu improves workflow efficiency, quality and patient outcomes in diagnostic imaging. Our software solution Cerebriu Apollo achieves this by automating image acquisition protocols and triage during MRI brain acquisition providing decision support at key stages of the diagnostic process. Ultimately this results in improved productivity, prioritizing the right patients at the right time and less stress for clinicians.